Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma-Reference-Cited by-同舟云学术

Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

Published:2021-02 Issue:2 Volume:21 Page:97-105
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Porcu Pierluigi,Hudgens Stacie,Horwitz Steven,Quaglino Pietro,Cowan Richard,Geskin Larisa,Beylot-Barry Marie^ORCID,Floden Lysbeth^ORCID,Bagot Martine,Tsianakas Athanasios,Moskowitz Alison,Huen Auris^ORCID,Dreno Brigitte,Dalle Stéphane,Caballero Dolores,Leoni Mollie^ORCID,Dale Stephen,Herr Fiona,Duvic Madeleine

Funder

National Cancer Institute

Kyowa Kirin Pharmaceutical Development

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference22 articles.

1. Changing incidence trends of cutaneous T-cell lymphoma;Korgavkar;JAMA Dermatol,2013

2. Review of the treatment of mycosis fungoides and Sézary syndrome: a stage-based approach;Horwitz;J Natl Compr Canc Netw,2008

3. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat;Meyer;Acta Derm Venereol,2010

4. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression;Kim;Arch Dermatol,2003

5. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases;Chren;Arch Dermatol,1997

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the pharmacological management of cutaneous T-cell lymphoma;Expert Opinion on Pharmacotherapy;2024-05-02

2. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22

3. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

4. Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients;Journal of the European Academy of Dermatology and Venereology;2024-01-26

5. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01